Trials / Completed
CompletedNCT01993823
Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis
A Phase III, Multicenter, Randomized, Double-blind, Parallel Group, Active Treatment-controlled Study Assessing the Safety and Efficacy of G238 Compared to Clotrimazole 1% Otic Solution in Patients With Otomycosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 190 (actual)
- Sponsor
- Salvat · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of G238 for the treatment of otomycosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | G238 | Five drops into the ear canal twice daily for 14 days |
| DRUG | Clotrimazole | Five drops into the ear canal twice daily for 14 days |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2013-11-25
- Last updated
- 2017-04-04
- Results posted
- 2017-02-13
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01993823. Inclusion in this directory is not an endorsement.